Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Eur Urol. 2018 May 16;74(2):197–203. doi: 10.1016/j.eururo.2018.05.003

Fig. 4.

Fig. 4

Net benefit curves comparing the PBCG model for high-grade risk to the PCPTRC and the strategy of referring to biopsy all men. (A) North American cohorts. (B) External validation on European cohorts.

PBCG = Prostate Biopsy Collaborative Group; PCPTRC = Prostate Cancer Prevention Trial risk calculator.